Table 2 Clinical prognostic features of CCC patients
Prognostic factors | Cases (%) | Univariate | Multivariate | |
|---|---|---|---|---|
| Â | 96(100) | Pc | HR (95% CI) | Pd |
Age (years) | Â | 0.524 | Â | 0.292 |
  ≤ 54 (median) | 50(52.1) |  | 1.000 |  |
  > 54 (median) | 46(47.9) |  | 0.980(0.944–1.017) |  |
FIGO Stage | Â | 0.000 | Â | 0.007 |
 Early(I + II) | 64(66.7) |  | 1.000 |  |
 Late(III + IV) | 32(33.3) |  | 4.660(1.533–14.167) |  |
Residual tumor (cm) | Â | 0.115 | Â | 0.541 |
  ≤ 1 | 93(96.9) |  | 1.000 |  |
  > 1 | 3(3.1) |  | 1.690 (0.314–9.080) |  |
Ascites | Â | 0.005 | Â | 0.338 |
 No | 53(55.2) |  | 1.000 |  |
 Yes | 43(44.8) |  | 1.613(0.606–4.290) |  |
Endometriosis | Â | 0.121 | Â | 0.568 |
 No | 78(81.3) |  | 1.000 |  |
 Yes | 18(18.7) |  | 0.647(0.144–2.894) |  |
Chemotherapeutic response | Â | 0.000 | Â | 0.003 |
 Platinum sensitive | 64(72.7) |  | 1.000 |  |
 Platinum resistant | 24(27.3) |  | 7.230(1.992–26.237) |  |